CDC's Arbovirus Diagnostic Laboratory

CDC's Arbovirus Diagnostic Laboratory
Name	Arbovirus Diagnostic Laboratory
Established	1940s
Location	Atlanta, Georgia
Agency	Centers for Disease Control and Prevention
Type	Public health laboratory

CDC's Arbovirus Diagnostic Laboratory is a specialized diagnostic unit within the Centers for Disease Control and Prevention that provides clinical and public health testing, research, and reference services for arthropod‑borne viruses. The laboratory supports patient care, outbreak response, and surveillance by applying serologic, molecular, and virologic methods for pathogens including flaviviruses, alphaviruses, and bunyaviruses. It integrates laboratory science with epidemiologic partners such as state health departments, the World Health Organization, and academic centers to guide prevention and control of vectorborne diseases.

Overview

The laboratory functions as a national reference center for arboviruses and operates alongside entities such as National Institutes of Health, Food and Drug Administration, Association of Public Health Laboratories, WHO/PAHO, and state public health laboratories in Georgia, Texas, and California. It provides confirmatory testing for viruses like West Nile virus, Zika virus, Dengue virus, Yellow fever, and Eastern equine encephalitis virus, and supports clinical care teams at institutions such as Emory University Hospital, Johns Hopkins Hospital, Mayo Clinic, and military medical centers including Walter Reed National Military Medical Center. The laboratory collaborates with academic research groups at Harvard Medical School, University of California, San Francisco, and Columbia University to validate assays and develop diagnostics.

History and Development

Origins trace to federal efforts in the mid‑20th century that linked to programs at Rockefeller Foundation field stations and cooperative work with the Pan American Health Organization following epidemics in the Americas. The lab expanded after recognition of St. Louis encephalitis outbreaks and development of cell culture and complement fixation tests at university centers like Yale University and University of Pennsylvania. Advances in molecular diagnostics from laboratories at Stanford University, Massachusetts Institute of Technology, and Centers for Disease Control and Prevention laboratories accelerated adoption of RT‑PCR and sequencing in the 1990s and 2000s, with pivotal responses during the West Nile virus outbreak of 1999–2000 and the Zika virus epidemic of 2015–2016. Key institutional interactions have included cooperative agreements with Centers for Medicare & Medicaid Services and technology transfer partnerships with manufacturers such as Roche and Thermo Fisher Scientific.

Diagnostic Services and Testing Methods

The laboratory performs a suite of assays used clinically and for public health: virus isolation in cell lines developed from work at National Institutes of Health, serology including plaque reduction neutralization tests refined in collaboration with Johns Hopkins University, IgM capture ELISA methods adapted from protocols at University of Texas Medical Branch, and nucleic acid amplification tests such as RT‑PCR and next‑generation sequencing techniques pioneered with partners at Broad Institute and Sanger Institute. It maintains standardized panels for differential diagnosis among Dengue virus, Zika virus, Chikungunya virus, La Crosse encephalitis virus, and Powassan virus, implementing quality controls aligned with standards from Clinical and Laboratory Standards Institute and accreditation from entities like College of American Pathologists. Laboratory workflows support specimen types referenced in clinical guidance from American Society for Microbiology and clinical advisory committees such as Advisory Committee on Immunization Practices.

Research and Surveillance Contributions

The laboratory contributes to genomic surveillance through sequencing networks linked to GISAID‑style platforms and works with vector ecology groups at Centers for Disease Control and Prevention Division of Vector‑Borne Diseases, Smithsonian Institution, and university entomology programs at Cornell University and University of Florida. It has published lineage and phylogenetic analyses referencing methods developed at Cold Spring Harbor Laboratory and European Bioinformatics Institute, informing vaccine development programs at Sanofi Pasteur and GSK. The lab provides data to international surveillance efforts coordinated with Pan American Health Organization and outbreak response teams dispatched under the International Health Regulations (2005). Its surveillance output has informed travel guidance from U.S. Department of State and vaccination policy deliberations by bodies such as World Health Organization technical advisory groups.

Biosafety and Quality Assurance

Operations adhere to biosafety frameworks promulgated by Centers for Disease Control and Prevention, Occupational Safety and Health Administration, and international standards from World Health Organization. The facility maintains biosafety level designations consistent with handling requirements for arboviruses and implements external quality assessment programs administered by Association of Public Health Laboratories and proficiency testing providers associated with College of American Pathologists. Quality management systems align with requirements from Clinical and Laboratory Standards Institute, and diagnostic validation often follows guidance from the Food and Drug Administration for emergency use authorization of assays during outbreaks. Training initiatives are run jointly with academic partners including Emory University Rollins School of Public Health and Johns Hopkins Bloomberg School of Public Health.

Collaborations and Public Health Impact

The laboratory's partners include federal agencies such as Department of Health and Human Services, international agencies like World Health Organization, academic institutions including Yale School of Public Health, and non‑governmental organizations such as Bill & Melinda Gates Foundation‑funded projects. Its diagnostic confirmation and surveillance activities have directly impacted public health actions during events like the 2012 West Nile virus outbreak, the 2015–2016 Zika virus epidemic, and responses to localized Eastern equine encephalitis incursions, guiding vector control operations by municipal health departments and informing vaccine policy decisions by manufacturers and advisory committees. Training and capacity‑building efforts have strengthened regional laboratory networks across the Americas and Africa through collaborations with Pan American Health Organization and Africa Centres for Disease Control and Prevention.

Category:Public health laboratories Category:Centers for Disease Control and Prevention